lobbying_activities: 912112

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
912112	3eda5ee3-98f5-4db9-b7db-657736456ac0	Q1	THE OB-C GROUP, LLC	29802	ELI LILLY	2010	first_quarter	PHA	HR 1548, Pathway for Biosimilars Act: entire bill. HR 4872, Health Care and Education Reconciliation Act of 2010: matters relating to pharmaceutical manufacturers in Health Care Reform including Biosimilars. HR 3590: Patient Protection and Affordable Care Act; matters relating to pharmaceutical manufacturers in Health Care Reform including Biosimilars. No specific bill number: matters relating to pharmaceutical manufacturers in Health Care Reform including Biosimilars.	HOUSE OF REPRESENTATIVES,SENATE	30000		0	0	2010-04-14T11:43:54.270000-04:00